Gayed, M.M.; Jung, S.-H.; Huggins, E.; Rodriguez-Rassi, E.; DeArmey, S.; Kishnani, P.S.; Stiles, A.R.
Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease. Int. J. Mol. Sci. 2022, 23, 14938.
https://doi.org/10.3390/ijms232314938
AMA Style
Gayed MM, Jung S-H, Huggins E, Rodriguez-Rassi E, DeArmey S, Kishnani PS, Stiles AR.
Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease. International Journal of Molecular Sciences. 2022; 23(23):14938.
https://doi.org/10.3390/ijms232314938
Chicago/Turabian Style
Gayed, Matthew M., Seung-Hye Jung, Erin Huggins, Eleanor Rodriguez-Rassi, Stephanie DeArmey, Priya Sunil Kishnani, and Ashlee R. Stiles.
2022. "Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease" International Journal of Molecular Sciences 23, no. 23: 14938.
https://doi.org/10.3390/ijms232314938
APA Style
Gayed, M. M., Jung, S.-H., Huggins, E., Rodriguez-Rassi, E., DeArmey, S., Kishnani, P. S., & Stiles, A. R.
(2022). Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease. International Journal of Molecular Sciences, 23(23), 14938.
https://doi.org/10.3390/ijms232314938